Linio Biotech

Regenerative tissue platform (Tience) for skin and soft-tissue defect treatment, used by clinicians in the Nordics

Helsinki, FinlandFounded 2017linio-biotech.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Linio Biotech

Linio Biotech develops Tience, a platform technology for skin defect treatment based on proprietary research into human adipose tissue. The company describes its cell-free, sterile product as designed to activate the body's own regenerative mechanisms.

Its Tience technology is already used by clinicians in the Nordics. The company is developing next-generation regenerative products on the Tience platform for aesthetic and therapeutic indications, and says it has raised over €10 million through equity investments and public grants.

The company was officially established in 2017 in Helsinki, Finland, following research that began in 2005 at Tampere University. Its leadership includes CEO Karita Reijonsaari and founder and CTO Riina Uusmies, and it has a Board of Directors that includes a member based in New York.

Product: Tience platform technology for skin and soft-tissue defect treatment, based on human adipose tissue research

Jobs at Linio Biotech

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Medicortex Finland

    Develops biomarker-based diagnostic tests for traumatic brain injury and concussion
    Turku, FinlandBiotech & pharmaFounded 2014
    New on Evolc
  • Misvik Biology

    Cancer drug screening and preclinical research services for biopharma companies and academic institutions
    Turku, FinlandBiotech & pharmaFounded 2014
    New on Evolc
  • Nadmed

    NAD and glutathione assay kits and laboratory analysis for clinical and research laboratories
    Helsinki, FinlandBiotech & pharmaFounded 2022
    Young companyNew on Evolc
  • NMR Solutions

    NMR data analysis software and interpretation services for organizations using proton NMR spectroscopy
    Kuopio, FinlandBiotech & pharmaFounded 2015
    New on Evolc
  • Omgenis

    Develops a single-use periodontal bone reconstruction system for dental and periodontal care
    Turku, FinlandBiotech & pharmaFounded 2026
    Young companyNew on Evolc
  • Origin by Ocean

    Bio-based fucoidan and alginate ingredients from invasive Sargassum for cosmetics, food and technical product formulators
    Espoo, FinlandBiotech & pharmaFounded 2019
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • AWS
  • Cloudflare
  • Plausible
  • Webflow